© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 14, 2021
Before the COVID-19 pandemic, pharmacy technicians spent most of their shifts helping patients, billing insurance, stocking the pharmacy area, dispensing prescriptions, and other administrative duties. However, COVID-19 quickly changed that.
Errors related to extended-release opioids and COVID-19 vaccines warrant attention and should be a priority.
April 13, 2021
Nearly half of independent pharmacists surveyed by the National Community Pharmacists Association are not getting enough or any doses of the COVID-19 vaccine.
Pharmacists can play an integral role when it comes to the management of diabetes, whether by educating patients on lifestyle changes, medications, or disease state management.
From countless hours of studying to participating in pharmacy organizations to volunteering in the community, it’s no surprise that student pharmacists often struggle to find balance as a well-rounded student.
As the FDA and CDC have paused use of the Johnson & Johnson COVID-19 vaccine in the United States, research is ongoing to understand whether cerebral venous sinus thrombosis (CVST) is directly linked to the vaccine.
A study comparing the efficacy of the 2 commercially available herpes zoster (HZ) vaccines, the live zoster vaccine and the non-live recombinant zoster vaccine, found that RZV has both higher efficacy and broader use cases, according to the authors.
The FDA and CDC said that 6 women experienced cerebral venous thrombosis, an extremely rare disorder associated with blood clotting, 6 to 16 days after the Johnson & Johnson COVID-19 vaccine was administered.
April 12, 2021
The pharmacist is the last barrier between a patient and a drug, which is why it's critical for pharmacists to check for allergies, potential drug interactions, patient understanding of how to use the drug, and whether the prescription is appropriate for the diagnosis.
Among patients with HIV who had not been diagnosed with heart disease at the beginning of the study, the risk of developing heart disease, heart failure, or stroke for the first time was 90% higher among those taking beta-blockers.